Provider FAQs – COVID-19

Updated July 7, 2020

Below you will find FAQs on the following:

 

Do not delay care: Please help us remind families that if their child needs emergency or urgent care, not to delay taking them to the ED or urgent care. Delaying care for potentially serious concerns can put their child at risk for more severe complications. Seattle Children’s ED and urgent care clinics are open and have capacity.

We have joined forces with WSHA and 111 hospitals across the state in a public education campaign to encourage people to get care when they need it, including well-child checks and vaccinations for children.

We are committed to keeping our patients, families and workforce safe from exposure to COVID-19. Families can find information here about the robust safety measures we have in place.

Thank you for your partnership.

 

Information about COVID-19 Testing

Q: Who is being tested for COVID-19?

A: Seattle Children’s continues to update its COVID-19 testing guidelines as the situation changes.

Given ongoing local transmission in WA State and concerns around asymptomatic infection and risks to healthcare workers performing aerosol generating procedures, we recommend the following:

Test the following for COVID-19:

  • Any patient with signs or symptoms potentially consistent with COVID-19, including: fever, cough, shortness of breath, fatigue, headache, chills, muscle or body aches, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea.
    • These patients may be tested; use clinical judgment on whether to test if symptoms are explained by another source
    • Patients involved in an illness cluster in a care facility or institution (e.g., those who live in a nursing home or group home)
    • Known close exposure to a confirmed COVID-19 case
  • All patients at admission to the hospital
  • All patients 48-72 hours prior to a planned aerosol-generating procedure, unless they tested negative within the last two weeks and have been continuously hospitalized without new respiratory symptoms
  • All patients, regardless of symptoms, who report they are close contacts of a case. A close contact is defined as someone who was within 6 feet of an infected person for at least 15 minutes starting from 2 days before illness onset (or, for asymptomatic clients, 2 days prior to positive specimen collection) until the time the patient is isolated. Close contacts who test negative for COVID-19 still need to remain quarantined for 14 days after their last date of exposure.
  • Asymptomatic patients who are:
    • Individuals exposed to COVID-19 during an outbreak in a congregate setting (e.g., long term care facility, shelter, correctional setting, agricultural worker temporary housing, meat-packing plant, etc.).
    • Persons from racial and ethnic minority groups disproportionately affected by adverse COVID-19 outcomes; currently this includes Hispanics and Latinos, Native Hawaiian–Pacific Islanders, African Americans, American Indians and Alaska Natives, whose work, living circumstances or inequitable access to healthcare, and higher rates of comorbid conditions puts them at higher risk of severe disease
    • Persons who are pregnant and present in labor
    • All newborns born to parents who are suspected of having or who have tested positive for COVID-19.
  • Pre-BMT patients will be tested per SCCA protocol.
  • Hem-Onc patients:
    • Who are symptomatic, regardless of when their last test was
    • 72 hours prior to scheduled admit for chemo if not tested in the prior 2 weeks
    • 72 hours prior to apheresis for cell collection
    • 72 hours prior to t-cell infusion
    • 72 hours prior to offsite procedures, including IR/OR/MAST
    • 72 hours prior to radiation and Q 2 weeks while on XRT if being sedated for radiation
    • 72 hours prior to their hem/onc clinic procedure room procedure unless they have been tested within the prior 2 weeks

DO NOT test the following groups:

  • Asymptomatic outpatients not meeting above criteria.

 

Educate all patients you test

If COVID-19 is being considered, whether testing is performed or not, provide the following guidance documents to patients, and emphasize the need to isolate for ill persons and self-quarantine for exposed contacts. Healthcare providers play a critical role in slowing transmission by identifying COVID cases recommending early isolation.

 

Community COVID-19 testing: We recommend that providers follow the Seattle Children’s guidelines above when referring patients for SARS-CoV-2 COVID testing at our drive-through site at SPLC or our Urgent Care locations (testing is done on-site at urgent cares, not via drive-through). Read more information about community COVID-19 testing offered by Seattle Children’s.

 

Q: For pre-operative testing at Seattle Children’s, what happens when patients live far away or cannot get tested in time?

A: We are screening all pre-operative patients for COVID-19. This includes patients who will have a procedure in an operating room and those who need anesthesia in Radiology. Families who have a procedure or surgery scheduled receive a reminder call 72 hours before surgery from the pre-procedure nurses. These tests need to be collected 24 to 72 hours prior to surgery and are being offered at our drive-through testing location at our Sand Point Learning Center (SPLC) north of the hospital, or during an in-person appointment at one of our four urgent care locations in Bellevue, Everett, Federal Way and Seattle.

When 24 Hour Tests are Necessary

Requests for testing within 24 hours may come up for cases that are added last minute. These families can come to Seattle to have their testing performed within the 24 hour period. Results from external facilities should be faxed to the Seattle Children’s Pre-Anesthesia COVID-19 testing line at 206-987-2060 by 5 p.m. the day before procedure.

We understand that timely testing is not widely available outside the Seattle area. Perioperative Services will be working with families traveling from further away to help coordinate early arrival to the Seattle area to allow testing.

There will be patients who will be unable to undergo testing prior to surgery due to distance or urgency of procedure. If testing cannot be conducted, there will be a clinical escalation to decide if the procedure should:

  • Be postponed until testing can be completed
  • Proceed – with appropriate precautions in place to protect our workforce

As a reminder, Seattle Children’s is informing families of the testing requirement, placing the screening order at SPLC or one of our Urgent Care locations and communicating the test results. All testing is ordered by Seattle Children’s providers.

Q: When should a second test be obtained for SARS-CoV2?

A: Rationale for obtaining a 2nd testing during a course of illness:

  • Well-designed PCR tests for SARS-CoV2 have high analytical sensitivity, but clinical sensitivity is unknown due to lack of clinical gold standard.
  • Clinical sensitivity is dependent on where the patient is in the course of their illness and the associated viral load (viral load decreases later in the course of illness).
  • SARS-CoV2 appears to have anatomical tropism. For instance, in general, shedding persists for longer in lower respiratory tract specimens and as a result, lower respiratory tract specimens have higher sensitivity than upper respiratory tract specimens.
  • Our testing strategy at Seattle Children’s calls for utilizing upper respiratory tract specimens as the primary specimen because it is not always possible and is often not easy to obtain a lower tract specimen from a pediatric patient.
  • However, when suspicion for SARS-CoV2 disease (COVID-19) is high, consideration should be given to obtaining a second test and preferably from the lower respiratory tract if possible.

Procedure:

Identify which patients have a higher pretest probability of COVID-19:

  • Rapid or severe respiratory decompensation without alternate explanation with or without chest CT findings consistent with COVID-19

OR

  • Lower respiratory tract disease (cough, increased RR, SOB, or 02 requirement) without another etiology

AND one of the following:

    • Close contact exposure to known COVID+

 OR

    • Patient lives in facility / group home

OR

    • Radiological evidence consistent with COVID-19 (CXR: bilateral infiltrates, not lobar consolidation; CT: ground glass opacities)

Preferred 2nd samples:

  • Productive cough: collect sputum if possible
  • No cough or non productive cough:
    • Preferred specimens: induced sputum, deep suctioning through ETT, BAL
    • If above not possible or feasible: consider repeating middle turbinate (MT) swab or other upper respiratory tract sampling

Isolation Considerations based on 2nd SARS-CoV2 test results

  • Lower respiratory tract specimen
    • Positive: SIU
    • Negative: Can transition to viral respiratory precautions (due to pre-existing respiratory symptoms/signs)
  • Repeat MT swab or other upper respiratory tract sampling
    • Positive: SIU
    • Negative:
      • High index of suspicion of COVID-19: remain in SIU
      • Lower index of suspicion of COVID-19: discuss with ID to consider whether strict isolation or viral respiratory isolation outside SIU is appropriate.

Q: How many children have tested positive?

A:As of July 6, Seattle Children’s had tested 6,579 patients of which 70 patients tested positive and 11 inconclusive, for an overall positivity rate of 1.2%, a rate which has remained stable over the last several months.

COVID-19 cases in children make up less than 2% of reported cases in the U.S., according to the CDC’s Morbidity and Mortality Weekly Report (April 7, 2020).

Q: How will I know if you are treating my patient for COVID-19?

A: If your patient is seen at Seattle Children’s for suspected COVID-19 (or any other condition), you will receive our standard fax communications regarding ER summary, admission, discharge etc.

Q: Does Seattle Children’s offer drive-through testing for staff with symptoms of COVID-19?

A: On March 13, Seattle Children’s began offering testing for workforce members who have symptoms of COVID-19 (fever, cough, difficulty breathing). At this time testing is available to Seattle Children’s workforce who have a badge. This includes active community medical staff members with a Seattle Children’s badge.

Q: Is Seattle Children’s offering COVID-19 testing for the pediatric community?

A: Yes, we are pleased to announce that as of May 11, 2020 Seattle Children’s is offering drive-through SARS-CoV-2 COVID testing to the pediatric community at our Sand Point Way Learning Center and in-clinic testing at our four Urgent Care locations (Seattle, Bellevue, Everett and Federal Way). Community providers who wish to have their patients tested at Seattle Children’s should submit this requisition form to authorize the patient’s test. Read more information about our COVID-19 testing for the pediatric community.

Q: Where else can pediatric patients get tested?

A: Public Health – Seattle & King County has opened two new large-scale testing sites in Seattle for COVID-19; they are in SODO (3820 6th Ave. S.) and Bitterlake (12040 Aurora Ave. N.) and free to everyone regardless of insurance or immigration status.

Community Testing Sites

Q: Will you notify PCPs of their patients’ coronavirus test results?

A: Yes, PCPs will receive notification from Seattle Children’s of their patient’s test result, regardless of whether it is positive or negative or whether the test is ordered by Seattle Children’s or the PCP. If the test is negative, PCPs can expect to receive a copy of our standard lab report via fax. (Please note: inconclusive results are being treated as “positive” until confirmed by the State or CDC.)

When PCPs order the test, results will be sent only to the PCP and not the family.

  • Results from our drive-through location at Sand Point Learning  Center will be provided same-day.
  • Results from our regional urgent care clinics will be provided same-day or, if they don’t make it in to the day’s final run to the lab at 6 p.m., they will be ready by 10 a.m. the next day.
  • If you don’t receive your results within the time expected, please call our clinical lab at 206-987-2102 for assistance.

When Seattle Children’s orders the test (as opposed to a PCP ordering a test), we are also providing test results to families and directing them to contact their child’s PCP if their child’s test is negative and they have follow-up questions.  We are letting families know we will have their results within approximately 24 hours of testing.

For more details about testing methodology, interpretation and reliability, see FAQ: Clinical Laboratory Testing for COVID-19 at Seattle Children’s.

Q: Does Seattle Children’s offer antibody testing?

A: Yes, Seattle Children’s and UW Medicine labs are performing the Abbott SARS-CoV-2 IgG immunoassay on the ARCHITECT instrument. This is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 nucleocapsid protein in human serum and plasma.

This test is not FDA-approved for diagnosis of infection due to SARS-CoV2; however, the data presented in the package insert demonstrate it is a sensitive test for detecting past SARS-CoV2 infection. It also appears to be specific; however, more testing in the setting of other human coronavirus infections is needed. Thus a positive test likely indicates past infection due to SARS-CoV2 while a negative test indicates that a person likely did NOT experience infection with SARS-CoV2. See the indications for testing and the FAQs below for more information.

Community providers can order the test the same way they currently order other lab tests at Seattle Children’s; no special requisition is needed. Test details are here.

Indications for serological testing for SARS-CoV-2 (COVID-19)

  • Patients who have had a prior illness consistent with COVID-19 more than 21 days ago and either tested negative or were not tested
  • Patients who had a known exposure to SARS-CoV-2 more than 21 days ago

CAUTION:

  • Serological testing is NOT indicated for diagnosis of acute infection and should not be ordered while a patient is being investigated for active SARS-CoV-2 infection
  • For patients with new or persistentCOVID-19 symptoms, or if there is concern for active infection, molecular testing (PCR) with a nasopharyngeal swab is recommended prior to considering serologic testing
  • It is unknown if a positive antibody test indicates any level of short or long term protection against SARS-CoV-2; antibody test results should not be used to guide return-to-work decisions
  • Immunocompromised patients who have COVID-19 may have a delayed antibody response and produce levels of antibody which may not be detected as positive by the assay

At this time, it is not known whether the presence of antibodies confers protection from reinfection with SARS-CoV-2, how long the antibody response lasts, or the association between antibody response and clinical outcomes of individuals with COVID-19.

Sensitivity: According to published series, at 2 weeks after onset of symptoms, sensitivity is over 50%. At approximately 25 days after symptomatic infection in hospitalized patients, the sensitivity approaches 100%. The Abbott product insert reports higher sensitivity, with 91% sensitivity by 14 days after symptom onset. The sensitivity of the test among subjects with asymptomatic infection is unclear, and the duration of positive results (seropositivity) is unknown.

 

 

Information about COVID-19 Treatment

Q: What are Seattle Children’s guidelines for treating COVID-19?

A: A multidisciplinary group of physicians at Seattle Children’s has developed a management guideline for patients with SARS-CoV-2 infection. Although there is no treatment with proven efficacy for COVID-19, this guidance will help with risk stratification and outlines evaluation and treatment approaches that should be considered. Current evidence for various investigational agents is also included. This guidance was developed with resources and capabilities at Seattle Children’s in mind. It will be updated periodically as more evidence becomes available.

The guidelines are currently being used by a multidisciplinary group at Seattle Children’s who review and discuss each patient before making recommendations based on current guidelines. These are general guidelines; as with most guidelines, clinical correlation is required.

For more information on treatment guidelines for COVID-19, visit the NIH’s Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.

  • Multisystem inflammatory syndrome in children (MIS-C): View Seattle Children’s Clinical Standard Work Pathway on recognition, evaluation and treatment for MIS-C.

Q: What do we know about risk factors for the pediatric population?

A: Early studies have shown that children of all ages are at risk for COVID-19, but that their disease course is less severe than adults.  Risk factors for more severe disease in children are poorly defined, but patients of all ages, including children and adolescents, may be at risk for more severe COVID-19 illness if they have chronic lung disease (including severe persistent asthma), heart disease (congenital heart defects), immunocompromising conditions, severe obesity, chronic kidney disease on dialysis, or chronic liver disease. These patients should be monitored closely for clinical decompensation.

Information about Telehealth

Q: Are you offering provider ambulatory telemedicine and telephone visits?

A: Seattle Children’s is swiftly changing our care model to meet the clinical needs of patients during the COVID-19 outbreak by offering telehealth visits instead of in-person appointments when medically possible. Nearly all Seattle Children’s specialties are performing some level of telehealth and have processes in place to accommodate patients when clinically appropriate.

We are working to shift in-person clinic visits to telehealth visits when possible. Learn more.

The Office of Civil Rights (OCR) issued a statement that allows enforcement discretion of normal HIPAA rules.

OCR will not impose penalties for noncompliance with the regulatory requirements under the HIPAA Rules in connection with the good faith provision of telehealth during the COVID-19 nationwide public health emergency. This means that non-public-facing applications are approved during this period of time. However, if these applications are linked to your personal device, patients will see your personal information (e.g., cell phone number).

 

 

Changes to Ambulatory Clinics, Services and Scheduling

Q: Are all Seattle Children’s clinic locations open and seeing patients?

A: All of our sites of care are open and seeing patients except our Outpatient Psychiatry and Behavioral Medicine Clinic at Overlake and South Sound Cardiology in Centralia, both of which remain closed for in-person visits.

Locations that were temporarily closed this spring due to COVID-19 are back open (Sleep at Overlake, Olympia Clinic, South Sound Cardiology clinics in Olympia and Tacoma) and have been increasing their in-person visits.

Q: What changes have you made to ambulatory appointment scheduling?

A: The following triage guidelines are in place through at least June 30 to ensure a consistent approach to scheduling ambulatory patients across all specialties and locations during COVID-19, including EKG and EEG appointments. The guidelines are intended to continue to provide needed care to patients, preserve PPE, and promote social distancing for our staff, providers, and community. Adhering to the standards will avoid the need to reschedule patients, decrease growth of scheduling backlog and access constraints, and allow for appropriate prioritization once standard operations resume.

These standards apply to currently scheduled patients and new scheduling requests, for new and return appointments:

Tier 1:  Patients who need to be seen in person by the provider before July 1

  • Clinical situation that could be compromised by delay in care and requires physical examination to support clinical decision-making

Tier 2: Patients who can be seen with a telephone or telehealth visit — can be scheduled at any time.

  • Follow up care where the physical exam is not essential to decision making
  • Key physical exam or imaging findings may be obtained by other means (e.g., PACS, photos, etc.)
  • Referrals/consults that can be assessed with a telephone or telehealth visit 

Tier 3: Patients who can be rescheduled or placed in the queue for scheduling when we resume normal business operations — can be placed in a queue to schedule an in-person visit at a later date.

  • Patient condition does not suggest clinical urgency
  • Family prefers an in-person visit
  • Clinic does not have capacity or ability to provide a telehealth or telemedicine visit
  • Referral/consult cannot be assessed with a telephone or telehealth visit

Q: Any other changes in scheduling?

A: Seattle Children’s Contact Center has shortened its hours to close to inbound calls at 5 p.m. rather than 6 p.m. New inbound calling hours are 7 a.m. to 5 p.m. Outbound calls will still occur until 6 p.m.

Q: Are surgeries continuing?

A: In accordance with updated guidance from Governor Jay Inslee in May, Seattle Children’s is resuming some elective surgeries and procedures. We will be calling patient families in the coming weeks to reschedule those whose surgeries and procedures were cancelled earlier this spring in response to the CDC’s recommendations for Seattle-King, Pierce and Snohomish County. PCPs will be notified of their patients’ rescheduled procedures and surgeries through our standard channels.

We continue to perform urgent surgeries and procedures.

Q: Are there any changes to Seattle Children’s outpatient radiology services?

A: We are continuing to offer a full range of imaging services including diagnostic outpatient x-ray in Bellevue, Federal Way, Everett, and Seattle – but we ask that you please help us promote social distancing and preserve supplies and equipment by delaying all non-emergent imaging studies. All families will be asked a series of screening questions before they enter the building. Families who present with respiratory symptoms or influenza-like illness will be put in strict isolation. We may consider less investigative studies when applicable.

X-rays now require an appointment: Families who need diagnostic x-rays at Seattle Children’s are now required to schedule an appointment.  We are no longer accepting walk-in patients. Families should call 206-987-2089 to schedule an appointment. Schedulers are available to schedule these studies from 7 a.m. to 6 p.m., Monday to Friday. We will evaluate urgency and consider less investigative studies when appropriate.

X-rays can still be done as part of an urgent care visit.

Q: Are there any changes to Seattle Children’s laboratory services?

A: Laboratory hours at our South Clinic in Federal Way and North Clinic in Everett have been slightly reduced to 7:45 a.m. to 4 p.m. on Saturdays (closed for lunch from 11 to 11:30 a.m.). Monday through Friday hours at these two clinics remain 7:30 a.m. to 6 p.m., closed Sunday. View our Laboratory Medicine and Pathology website for a full listing of all our lab locations and hours. Labs continue to be open to walk-in visits, with COVID-19 screening in place at entrances.

Q: Can families still use the hospital pharmacy?

A: In response to COVID-19, the Outpatient Pharmacy at Seattle Children’s hospital campus in Seattle now offers curbside pickup and mail order prescription options (some restrictions apply). Families who need to fill their child’s prescription on-site or request a refill should inquire with pharmacy staff to discuss pick-up or mail order options.

On-site pick up is still available 24 hours a day, 7 days a week at the hospital campus in Seattle. Prescriptions must be written by a Seattle Children’s physician.

 

 

Changes at our Hospital Campus

Q: Are you accepting older patients?

A: With other hospitals in the area already seeing patient surges that are straining their resources, Seattle Children’s has agreed to begin accepting inpatients up to and including age 21. Doing so will help provide additional space at other hospitals to serve the adult population.

Q: If one of my patients is an inpatient at Seattle Children’s, what can they expect?

A: The clinical staff and providers at Seattle Children’s are trained on the identification, isolation and treatment of COVID-19 and other infectious diseases. At this point in time:

  • If an inpatient does not have cold or flu-like symptoms, they will continue to receive care without change.
  • If the primary caregiver has symptoms of fever or cough, they should not visit.
  • To protect our patients, families and staff from a possible exposure to COVID-19, we currently allow only two primary caregivers to visit a patient.

The situation with COVID-19 is evolving and procedures for patient care will necessarily change to best protect patients, their families and staff.

Q: Has your visitor policy changed?

A: To maintain the social distancing guidelines that have been proven to help slow the spread of COVID-19, we have limited the number of people who enter our buildings.

  • Inpatient: each patient is allowed to have two parents or primary caregivers visit or stay with them. The two parents/caregivers must be the same people throughout the duration of the patient’s stay and follow our guidelines for monitoring themselves for signs of illness.
  • Clinics, Surgery Center, Urgent Care, Emergency Department and Research appointments: only one parent or caregiver may accompany a patient to an appointment or visit to any of these locations.

Q: Are you screening visitors?

A: All patients and visitors are being screened for COVID-19 at our facility entrances. As we learn more about the coronavirus and the symptoms it can cause, we’ll continue to assess our entrance screening process and make adjustments as necessary to help keep our workforce members and patients safe. Based on recent findings about the virus, we have added additional symptoms to our entrance screening process.

View our screening algorithms for:

Visitors to the Lab who screen positive will be escorted to a negative pressure room and have their labs drawn in the negative pressure room, rather than diverted to the ED.

Q: Is Palliative Care still available for consults?

A: Seattle Children’s Palliative Care program is temporarily scaling back its on-site availability at the hospital to minimize the risk of COVID-19 to staff, families and patients.

Below are guidelines for consulting Palliative Care plus information about their revised staffing model.

1)   For new consults, Palliative Care will accept consults with the following criteria:

  1. Patients who are nearing or who are at the end-of-life, including pain & symptom management
  2. Goals of care consults
  3. Complex medical decision making

2)   Except as noted above, in general Palliative Care will default to phone and virtual check-ins with patients and families but will provide in-person care if the family/team feels this is necessary and it is safe to do so.

3)    Monday through Friday, the team has decreased staffing on-site with others working remotely.

  1. On-site staffing includes two clinical staff on-site for new consults and to see patients/families
  2. There is no change to after-hours and weekend staffing (one medical provider available via on-call or through the paging operator)

4)    All outpatient consults will be via telehealth.

5)    If you are unsure if a consult is appropriate at this time, or have any questions or issues that the Palliative Care team can support, please do not hesitate to reach out to the team any time, 24/7 through the hospital operator. The team is happy to support providers and teams on primary palliative care skills.

6)    For communication with the Palliative Care team, for general questions, and patient updates/information, please use the Palliative Care Program distribution list at PediatricAdvancedCareTeam@seattlechildrens.org. For more acute issues, please page our on call attending or APP through the hospital operator.

The Palliative Care team looks forward to the time when they will be able to ramp their services back up and engage in the incredible collaborative service to patients and families with partners at Seattle Children’s and in the community.

 

 

Changes to ED or Urgent Care

Q: When should PCPs send patients to Seattle Children’s Emergency Department (or not)?

A: Please send your patients to Seattle Children’s Emergency Department if they need emergent treatment (see the criteria for being admitted). We are open and have precautions in place to keep patients, families and staff safe. Please call our ED Communications Center first at 206-987-8899.

Q: Are there any changes to Seattle Children’s Urgent Care?

A: Our Urgent Cares continue to have capacity. Only one caregiver is allowed to accompany a patient to their appointment.

 

 

Changes to Classes and Courses

Q: Are classes and courses continuing at Seattle Children’s?

A: Due to COVID-19, Children’s had to pause or significantly modify many education and training programs earlier this spring. A multidisciplinary work group has developed a plan to resume some high-priority education and training. The following categories will resume beginning June 16:

  • Required competency — Resume Basic Life Support (BLS); Neonatal Resuscitation Program (NRP); Pediatric Emergency Assessment, Recognition and Stabilization (PEARS); Cardiopulmonary Resuscitation (CPR); and Pediatric Advanced Life Support (PALS).
  • Academic partner education (students) — Resume with a limited number of students.
  • Competency simulations — Resume high-priority simulations such as central venous line placement, Code Blue, Code Purple, and new space.

Safety remains our top priority. All training and education activities will follow strict infection prevention protocols. We will provide additional information in the coming weeks. Dates are subject to change based on the rapidly-changing nature of the pandemic.

 

Additional Resources

If your patient has questions or is concerned about COVID-19, please refer to these resources from Washington State Department of Health:

For the most up-to-date information about COVID-19, please visit:

For additional information to support families, see:

Seattle Children’s Panel Discussions on COVID-19

  • COVID-19: The Seattle Children’s Experience: Seattle Children’s infectious disease and emergency medicine experts shared their experiences from the front lines at the epicenter of the COVID-19 outbreak in the United States. This event includes a Q&A on how to prepare. Watch the video.
  • Confronting Tragic Choices in the Midst of a Pandemic: Our regional disaster healthcare network is one of the few in the country that has been focused on planning around a severe pandemic. Watch our panel discussion on how decisions are made when resources are scarce.

Information Line for Families

Community members may call our COVID-19 information center at 1-833-987-2100 to learn how Seattle Children’s is responding to this pandemic or to schedule a COVID-19 test once it has been ordered by their PCP. The line is open 8 a.m. to 5 p.m., Monday through Saturday.

This information line does not provide:

  • Medical advice or symptom triage related to COVID-19 or other medical conditions. Families should talk with their primary care provider about care recommendations.
  • Test results or other information about COVID-19 testing. Families who were tested at a Seattle Children’s location should wait to be called with results.
  • Scheduling or cancelling appointments. Over the coming days and weeks, our clinics will call families to either reschedule or convert appointments to telemedicine or telephone visits when possible. Families should call their clinic directly for questions about upcoming appointments.